244 related articles for article (PubMed ID: 33454548)
1. Design, synthesis, and evaluation of liver-specific gemcitabine prodrugs for potential treatment of hepatitis C virus infection and hepatocellular carcinoma.
Stephenson AA; Cao S; Taggart DJ; Vyavahare VP; Suo Z
Eur J Med Chem; 2021 Mar; 213():113135. PubMed ID: 33454548
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors.
Şenkardeş S; Kaushik-Basu N; Durmaz İ; Manvar D; Basu A; Atalay R; Küçükgüzel ŞG
Eur J Med Chem; 2016 Jan; 108():301-308. PubMed ID: 26695731
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of oral prodrugs based on the structure of gemcitabine.
Zhao C; Xue X; Li G; Sun C; Sun C; Qu X; Li W
Chem Biol Drug Des; 2012 Sep; 80(3):479-88. PubMed ID: 22642666
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 2'-dihalo ribonucleotide prodrugs with activity against hepatitis C virus.
Chris Krueger A; Chen HJ; Randolph JT; Brown BS; Halvorsen GT; Heyman HR; Li T; Marvin CC; Shanley JP; Voight EA; Bow DAJ; Van Handel C; Peterkin V; Carr RA; Stolarik D; Dekhtyar T; Irvin ML; Krishnan P; Henry RF; Wagner R; DeGoey DA
Bioorg Med Chem; 2020 Jan; 28(1):115208. PubMed ID: 31740203
[TBL] [Abstract][Full Text] [Related]
5. Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine.
Tsume Y; Drelich AJ; Smith DE; Amidon GL
Molecules; 2017 Aug; 22(8):. PubMed ID: 28796151
[TBL] [Abstract][Full Text] [Related]
6. Bifunctional aryloxyphosphoramidate prodrugs of 2'-C-Me-uridine: synthesis and anti-HCV activity.
Maiti M; Gao LJ; Huang C; Ptak RG; Murray MG; De Jonghe S; Herdewijn P
Org Biomol Chem; 2016 Sep; 14(37):8743-8757. PubMed ID: 27714209
[TBL] [Abstract][Full Text] [Related]
7. Stereocomplex Prodrugs of Oligo(lactic acid)
Tam YT; Huang C; Poellmann M; Kwon GS
ACS Nano; 2018 Jul; 12(7):7406-7414. PubMed ID: 29957934
[TBL] [Abstract][Full Text] [Related]
8. β-D-2'-α-F-2'-β-C-Methyl-6-O-substituted 3',5'-cyclic phosphate nucleotide prodrugs as inhibitors of hepatitis C virus replication: a structure-activity relationship study.
Du J; Bao D; Chun BK; Jiang Y; Reddy PG; Zhang HR; Ross BS; Bansal S; Bao H; Espiritu C; Lam AM; Murakami E; Niu C; Micolochick Steuer HM; Furman PA; Otto MJ; Sofia MJ
Bioorg Med Chem Lett; 2012 Sep; 22(18):5924-9. PubMed ID: 22892115
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication.
Clark JL; Hollecker L; Mason JC; Stuyver LJ; Tharnish PM; Lostia S; McBrayer TR; Schinazi RF; Watanabe KA; Otto MJ; Furman PA; Stec WJ; Patterson SE; Pankiewicz KW
J Med Chem; 2005 Aug; 48(17):5504-8. PubMed ID: 16107149
[TBL] [Abstract][Full Text] [Related]
10. Nm 283, an efficient prodrug of the potent anti-HCV agent 2'-C-methylcytidine.
Pierra C; Benzaria S; Amador A; Moussa A; Mathieu S; Storer R; Gosselin G
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):767-70. PubMed ID: 16248033
[TBL] [Abstract][Full Text] [Related]
11. Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport.
Song X; Lorenzi PL; Landowski CP; Vig BS; Hilfinger JM; Amidon GL
Mol Pharm; 2005; 2(2):157-67. PubMed ID: 15804190
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of a gemcitabine phosphoramidate prodrug.
Wu W; Sigmond J; Peters GJ; Borch RF
J Med Chem; 2007 Jul; 50(15):3743-6. PubMed ID: 17602464
[TBL] [Abstract][Full Text] [Related]
13. Selective Activation of a Prodrug by Thioredoxin Reductase Providing a Strategy to Target Cancer Cells.
Li X; Hou Y; Meng X; Ge C; Ma H; Li J; Fang J
Angew Chem Int Ed Engl; 2018 May; 57(21):6141-6145. PubMed ID: 29582524
[TBL] [Abstract][Full Text] [Related]
14. Dual pro-drugs of 2'-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virus.
McGuigan C; Madela K; Aljarah M; Gilles A; Battina SK; Ramamurty CV; Srinivas Rao C; Vernachio J; Hutchins J; Hall A; Kolykhalov A; Henson G; Chamberlain S
Bioorg Med Chem Lett; 2011 Oct; 21(19):6007-12. PubMed ID: 21856153
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of Gemcitabine-Threonine Amide Prodrug Effective on Pancreatic Cancer Cells with Improved Pharmacokinetic Properties.
Hong S; Fang Z; Jung HY; Yoon JH; Hong SS; Maeng HJ
Molecules; 2018 Oct; 23(10):. PubMed ID: 30314360
[TBL] [Abstract][Full Text] [Related]
16. Derivatives of imidazotriazine and pyrrolotriazine C-nucleosides as potential new anti-HCV agents.
Draffan AG; Frey B; Fraser BH; Pool B; Gannon C; Tyndall EM; Cianci J; Harding M; Lilly M; Hufton R; Halim R; Jahangiri S; Bond S; Jeynes TP; Nguyen VT; Wirth V; Luttick A; Tilmanis D; Pryor M; Porter K; Morton CJ; Lin B; Duan J; Bethell RC; Kukolj G; Simoneau B; Tucker SP
Bioorg Med Chem Lett; 2014 Nov; 24(21):4984-8. PubMed ID: 25288185
[TBL] [Abstract][Full Text] [Related]
17. Nucleoside ester prodrug substrate specificity of liver carboxylesterase.
Landowski CP; Lorenzi PL; Song X; Amidon GL
J Pharmacol Exp Ther; 2006 Feb; 316(2):572-80. PubMed ID: 16223870
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiviral evaluation of 9-(S)-[3-alkoxy-2-(phosphonomethoxy)propyl]nucleoside alkoxyalkyl esters: inhibitors of hepatitis C virus and HIV-1 replication.
Valiaeva N; Wyles DL; Schooley RT; Hwu JB; Beadle JR; Prichard MN; Hostetler KY
Bioorg Med Chem; 2011 Aug; 19(15):4616-25. PubMed ID: 21719300
[TBL] [Abstract][Full Text] [Related]
19. Discovery of 4'-azido-2'-deoxy-2'-C-methyl cytidine and prodrugs thereof: a potent inhibitor of Hepatitis C virus replication.
Nilsson M; Kalayanov G; Winqvist A; Pinho P; Sund C; Zhou XX; Wähling H; Belfrage AK; Pelcman M; Agback T; Benckestock K; Wikström K; Boothee M; Lindqvist A; Rydegård C; Jonckers TH; Vandyck K; Raboisson P; Lin TI; Lachau-Durand S; de Kock H; Smith DB; Martin JA; Klumpp K; Simmen K; Vrang L; Terelius Y; Samuelsson B; Rosenquist S; Johansson NG
Bioorg Med Chem Lett; 2012 May; 22(9):3265-8. PubMed ID: 22472694
[TBL] [Abstract][Full Text] [Related]
20. 2'-Chloro,2'-fluoro Ribonucleotide Prodrugs with Potent Pan-genotypic Activity against Hepatitis C Virus Replication in Culture.
Zhou S; Mahmoud S; Liu P; Zhou L; Ehteshami M; Bassit L; Tao S; Domaoal RA; Sari O; Schutter C; Amiralaei S; Khalil A; Ollinger Russell O; McBrayer T; Whitaker T; Abou-Taleb N; Amblard F; Coats SJ; Schinazi RF
J Med Chem; 2017 Jul; 60(13):5424-5437. PubMed ID: 28595015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
